Verastem (FRA:2VSA) Marketable Securities : €26.50 Mil (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Verastem Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Verastem's Marketable Securities for the quarter that ended in Mar. 2024 was €26.50 Mil.

Verastem's annual Marketable Securities declined from Dec. 2021 (€69.92 Mil) to Dec. 2022 (€12.24 Mil) but then increased from Dec. 2022 (€12.24 Mil) to Dec. 2023 (€54.31 Mil).

Verastem Marketable Securities Historical Data

The historical data trend for Verastem's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verastem Marketable Securities Chart

Verastem Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

28.79

60.37

69.92

12.24

54.31

Verastem Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															13.02	-	66.22	54.31	26.50

Verastem Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Verastem (FRA:2VSA) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Verastem Marketable Securities Related Terms

Thank you for viewing the detailed overview of Verastem's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Verastem (FRA:2VSA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verastem Inc (FRA:2VSA) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

VSTM:USA 0LOV:UK

Address

117 Kendrick Street, Suite 500, Needham, MA, USA, 02494

Website

https://www.verastem.com

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Verastem (FRA:2VSA) Headlines

No Headlines